# Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy

> **NCT01469624** · NA · UNKNOWN · sponsor: **Shiraz University of Medical Sciences**

## Conditions studied

- Nephropathy

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT01469624
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** — (—)
- **Last updated:** 2011-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469624, "Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01469624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*